Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study

F. Wang, Y.T. Xiang, Gabor Ungvari, C.H. Ng, H.F.K. Chiu, W. Zheng, C.H. Tan, N. Shinfuku

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    ©2016 Dustri-Verlag Dr. K. Feistle.Objective: This study examined the proportion of overweight in schizophrenia inpatients in selected Asian countries and territories and its independent demographic and clinical correlates. Method: Data on 1,534 hospitalized schizophrenia patients in 9 Asian countries and territories were collected by a review of medical files supplemented by a clinical interview during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs, and Body Mass Index (BMI) were recorded using a standardized protocol and data collection procedure. For analyzes, BMI ≥ 25 kg/m2 was defined as overweight. Results: The proportion of overweight was 35.8% (549/1,534) in the entire sample, with 39.7% (224/564) in females and 33.5% (325/970) in males (p = 0.01) and with wide inter-country variations. Multiple logistic regression analysis revealed that after controlling for study sites, overweight was independently associated with more frequent use of mood stabilizers (p <0.001, odds ration (OR) = 1.4, 95% confidence interval (CI) = 1.1 - 1.8) and longer length of illness (p <0.001, OR = 1.6, 95% CI = 1.2 - 2.1) but was less likely found in male patients (p = 0.003, OR = 0.7, 95% CI = 0.5 - 0.8). Conclusions: The prevalence of overweight Asian schizophrenia patients is significantly lower than the reported figures among their Western counterparts. There is considerable variation in prevalence of overweight schizophrenia patients within Asian countries and territories.
    Original languageEnglish
    Pages (from-to)450-454
    JournalInternational Journal of Clinical Pharmacology and Therapeutics
    Volume54
    Issue number6
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Prescriptions
    Schizophrenia
    Research
    Confidence Intervals
    Body Mass Index
    Prescription Drugs
    Psychotropic Drugs
    Inpatients
    Logistic Models
    Regression Analysis
    Demography
    Interviews

    Cite this

    @article{323f466ace54486cb506c545480b17e0,
    title = "Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study",
    abstract = "{\circledC}2016 Dustri-Verlag Dr. K. Feistle.Objective: This study examined the proportion of overweight in schizophrenia inpatients in selected Asian countries and territories and its independent demographic and clinical correlates. Method: Data on 1,534 hospitalized schizophrenia patients in 9 Asian countries and territories were collected by a review of medical files supplemented by a clinical interview during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs, and Body Mass Index (BMI) were recorded using a standardized protocol and data collection procedure. For analyzes, BMI ≥ 25 kg/m2 was defined as overweight. Results: The proportion of overweight was 35.8{\%} (549/1,534) in the entire sample, with 39.7{\%} (224/564) in females and 33.5{\%} (325/970) in males (p = 0.01) and with wide inter-country variations. Multiple logistic regression analysis revealed that after controlling for study sites, overweight was independently associated with more frequent use of mood stabilizers (p <0.001, odds ration (OR) = 1.4, 95{\%} confidence interval (CI) = 1.1 - 1.8) and longer length of illness (p <0.001, OR = 1.6, 95{\%} CI = 1.2 - 2.1) but was less likely found in male patients (p = 0.003, OR = 0.7, 95{\%} CI = 0.5 - 0.8). Conclusions: The prevalence of overweight Asian schizophrenia patients is significantly lower than the reported figures among their Western counterparts. There is considerable variation in prevalence of overweight schizophrenia patients within Asian countries and territories.",
    author = "F. Wang and Y.T. Xiang and Gabor Ungvari and C.H. Ng and H.F.K. Chiu and W. Zheng and C.H. Tan and N. Shinfuku",
    year = "2016",
    doi = "10.5414/CP202526",
    language = "English",
    volume = "54",
    pages = "450--454",
    journal = "International Journal of Clinical Pharmacology and Therapeutics",
    issn = "0946-1965",
    publisher = "Dustri-Verlag Dr. Karl Feistle",
    number = "6",

    }

    Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study. / Wang, F.; Xiang, Y.T.; Ungvari, Gabor; Ng, C.H.; Chiu, H.F.K.; Zheng, W.; Tan, C.H.; Shinfuku, N.

    In: International Journal of Clinical Pharmacology and Therapeutics, Vol. 54, No. 6, 2016, p. 450-454.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study

    AU - Wang, F.

    AU - Xiang, Y.T.

    AU - Ungvari, Gabor

    AU - Ng, C.H.

    AU - Chiu, H.F.K.

    AU - Zheng, W.

    AU - Tan, C.H.

    AU - Shinfuku, N.

    PY - 2016

    Y1 - 2016

    N2 - ©2016 Dustri-Verlag Dr. K. Feistle.Objective: This study examined the proportion of overweight in schizophrenia inpatients in selected Asian countries and territories and its independent demographic and clinical correlates. Method: Data on 1,534 hospitalized schizophrenia patients in 9 Asian countries and territories were collected by a review of medical files supplemented by a clinical interview during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs, and Body Mass Index (BMI) were recorded using a standardized protocol and data collection procedure. For analyzes, BMI ≥ 25 kg/m2 was defined as overweight. Results: The proportion of overweight was 35.8% (549/1,534) in the entire sample, with 39.7% (224/564) in females and 33.5% (325/970) in males (p = 0.01) and with wide inter-country variations. Multiple logistic regression analysis revealed that after controlling for study sites, overweight was independently associated with more frequent use of mood stabilizers (p <0.001, odds ration (OR) = 1.4, 95% confidence interval (CI) = 1.1 - 1.8) and longer length of illness (p <0.001, OR = 1.6, 95% CI = 1.2 - 2.1) but was less likely found in male patients (p = 0.003, OR = 0.7, 95% CI = 0.5 - 0.8). Conclusions: The prevalence of overweight Asian schizophrenia patients is significantly lower than the reported figures among their Western counterparts. There is considerable variation in prevalence of overweight schizophrenia patients within Asian countries and territories.

    AB - ©2016 Dustri-Verlag Dr. K. Feistle.Objective: This study examined the proportion of overweight in schizophrenia inpatients in selected Asian countries and territories and its independent demographic and clinical correlates. Method: Data on 1,534 hospitalized schizophrenia patients in 9 Asian countries and territories were collected by a review of medical files supplemented by a clinical interview during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs, and Body Mass Index (BMI) were recorded using a standardized protocol and data collection procedure. For analyzes, BMI ≥ 25 kg/m2 was defined as overweight. Results: The proportion of overweight was 35.8% (549/1,534) in the entire sample, with 39.7% (224/564) in females and 33.5% (325/970) in males (p = 0.01) and with wide inter-country variations. Multiple logistic regression analysis revealed that after controlling for study sites, overweight was independently associated with more frequent use of mood stabilizers (p <0.001, odds ration (OR) = 1.4, 95% confidence interval (CI) = 1.1 - 1.8) and longer length of illness (p <0.001, OR = 1.6, 95% CI = 1.2 - 2.1) but was less likely found in male patients (p = 0.003, OR = 0.7, 95% CI = 0.5 - 0.8). Conclusions: The prevalence of overweight Asian schizophrenia patients is significantly lower than the reported figures among their Western counterparts. There is considerable variation in prevalence of overweight schizophrenia patients within Asian countries and territories.

    U2 - 10.5414/CP202526

    DO - 10.5414/CP202526

    M3 - Article

    VL - 54

    SP - 450

    EP - 454

    JO - International Journal of Clinical Pharmacology and Therapeutics

    JF - International Journal of Clinical Pharmacology and Therapeutics

    SN - 0946-1965

    IS - 6

    ER -